Form EFFECT X4 Pharmaceuticals, Inc
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 14, 2026 4:15 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northeast Ohio Medical University (NEOMED) Advances Healthcare Innovation Through New Health Data Science and Artificial Intelligence Initiatives
- Balerion Space Ventures Brings On Aaron Mitchell, Early Impulse Space Employee, as Venture Partner
- Technology Developer John Jesse Breslin Announces 3Hit.com, an Upcoming AI-Powered Chess Education Platform
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
